LEADER 01442oas  2200373 a 450 
001 9910695723503321
005 20080401085808.0
035   $a(CKB)5470000002372549
035   $a(OCoLC)123346008
035   $a(EXLCZ)995470000002372549
100   $a20070420b19uuuuuu  sa              
101 0 $aeng
135   $aurmnu||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 10$aAnnual adverse drug experience report$b[electronic resource]
210   $aRockville, Md. $cFood and Drug Administration, Center for Drug Evaluation and Research, Office of Epidemiology and Biostatistics, Division of Pharmacovigilance and Epidemiology, Surveillance and Data Processing Branch
215   $avolumes $cdigital, PDF file
300   $aDescription based on: 1995; title from title screen (viewed on Apr. 19, 2007).
300   $aLatest issue consulted: 1996.
517   $aAnnual adverse drug experience report 
606   $aDrugs$xResearch$zUnited States$vPeriodicals
606   $aDrugs$xSide effects$zUnited States$vPeriodicals
615  0$aDrugs$xResearch
615  0$aDrugs$xSide effects
712 02$aCenter for Drug Evaluation and Research (U.S.).$bSurveillance and Data Processing Branch.
801  0$bGPO
801  1$bGPO
801  2$bGPO
906   $aDOCUMENT
912   $a9910695723503321
996   $aAnnual adverse drug experience report$93470668
997   $aUNINA